pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-642b |
Genomic Coordinates | chr19: 45674932 - 45675008 |
Description | Homo sapiens miR-642b stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
Mature miRNA Information | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-642b-5p | |||||||||||||||||||||
Sequence | 10| GGUUCCCUCUCCAAAUGUGUCU |31 | |||||||||||||||||||||
Evidence | Not_experimental | |||||||||||||||||||||
Experiments | DRVs in miRNA |
|
||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | IL1F10 | ||||||||||||||||||||
Synonyms | FIL1-theta, FKSG75, IL-1HY2, IL-38, IL1-theta, IL1HY2 | ||||||||||||||||||||
Description | interleukin 1 family member 10 | ||||||||||||||||||||
Transcript | NM_173161 | ||||||||||||||||||||
Other Transcripts | NM_032556 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on IL1F10 | |||||||||||||||||||||
3'UTR of IL1F10 (miRNA target sites are highlighted) |
>IL1F10|NM_173161|3'UTR
1 GGAGACAGGAAACTGCGTTTTAGCCTTGTGCCCCCAAACCAAGCTCATCCTGCTCAGGGTCTATGGTAGGCAGAATAATG
81 TCCCCCGAAATATGTCCACATCCTAATCCCAAGATCTGTGCATATGTTACCATACATGTCCAAAGAGGTTTTGCAAATGT
161 GATTATGTTAAGGATCTTGAAATGAGGAGACAATCCTGGGTTATCCTTGTGGGCTCAGTTTAATCACAAGAAGGAGGCAG
241 GAAGGGAGAGTCAGAGAGAGAATGGAAGATACCATGCTTCTAATTTTGAAGATGGAGTGAGGGGCCTTGAGCCAACAAAT
321 GCAGGTGTTTTTAGAAGGTGGAAAAGCCAAGGGAACGGATTCTCCTCTAGAGTCTCCGGAAGGAACACAGCTCTTGACAC
401 ATGGATTTCAGCTCAGTGACACCCATTTCAGACTTCTGACCTCCACAACTATAAAATAATAAACTTGTGTTATTGTAAAC
481 CTCTAAAAAAAAA
Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545213. RNA binding protein: AGO2. Condition:Control
PAR-CLIP data was present in GSM545215. RNA binding protein: AGO4. Condition:Control
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | C8166 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462572. RNA binding protein: AGO2. Condition:C8166 NL4-3
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM545213 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000393197.2 | 3UTR | AGCCAAGGGAACGGAUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM545215 | |
---|---|
Method / RBP | PAR-CLIP / AGO4 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000393197.2 | 3UTR | AAAGCCAAGGGAACGGAUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM1462572 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | C8166 / C8166 NL4-3 |
Location of target site | ENST00000393197.2 | 3UTR | AAAGCCAAGGGAACGGAUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
40 hsa-miR-642b-5p Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT061567 | BTG2 | BTG anti-proliferation factor 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT131025 | ZDHHC5 | zinc finger DHHC-type containing 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT248297 | HOXC8 | homeobox C8 | ![]() |
![]() |
2 | 4 | ||||||
MIRT346049 | NPTX1 | neuronal pentraxin 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT443817 | SH3BP5L | SH3 binding domain protein 5 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT453003 | CCDC115 | coiled-coil domain containing 115 | ![]() |
![]() |
2 | 16 | ||||||
MIRT486363 | SORCS2 | sortilin related VPS10 domain containing receptor 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT487496 | IL1F10 | interleukin 1 family member 10 | ![]() |
![]() |
2 | 4 | ||||||
MIRT489593 | ZDHHC20 | zinc finger DHHC-type containing 20 | ![]() |
![]() |
2 | 10 | ||||||
MIRT494875 | ZNF865 | zinc finger protein 865 | ![]() |
![]() |
2 | 2 | ||||||
MIRT500352 | ZNF385A | zinc finger protein 385A | ![]() |
![]() |
2 | 2 | ||||||
MIRT533000 | ZFHX3 | zinc finger homeobox 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT534979 | PSAT1 | phosphoserine aminotransferase 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT539420 | ADAT2 | adenosine deaminase, tRNA specific 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT546832 | RAP1B | RAP1B, member of RAS oncogene family | ![]() |
![]() |
2 | 2 | ||||||
MIRT552046 | ALG1 | ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase | ![]() |
![]() |
2 | 2 | ||||||
MIRT562034 | KRAS | KRAS proto-oncogene, GTPase | ![]() |
![]() |
2 | 2 | ||||||
MIRT565591 | SLC35G1 | solute carrier family 35 member G1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT569809 | XKR4 | XK related 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT573407 | ARL6IP1 | ADP ribosylation factor like GTPase 6 interacting protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT615258 | DPF2 | double PHD fingers 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT616320 | CACNA1A | calcium voltage-gated channel subunit alpha1 A | ![]() |
![]() |
2 | 2 | ||||||
MIRT617607 | SHOX2 | short stature homeobox 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT642596 | C14orf180 | chromosome 14 open reading frame 180 | ![]() |
![]() |
2 | 2 | ||||||
MIRT643808 | ABCC12 | ATP binding cassette subfamily C member 12 | ![]() |
![]() |
2 | 2 | ||||||
MIRT646202 | DUSP10 | dual specificity phosphatase 10 | ![]() |
![]() |
2 | 2 | ||||||
MIRT648791 | VPS8 | VPS8, CORVET complex subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT650822 | LZTR1 | leucine zipper like transcription regulator 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT653992 | SECISBP2 | SECIS binding protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT655452 | PALM2 | paralemmin 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT660556 | ARF1 | ADP ribosylation factor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT702698 | IPO9 | importin 9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT708102 | IGF2BP1 | insulin like growth factor 2 mRNA binding protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT708674 | LY6G6D | lymphocyte antigen 6 family member G6D | ![]() |
![]() |
2 | 2 | ||||||
MIRT709773 | LY6G6F | lymphocyte antigen 6 family member G6F | ![]() |
![]() |
2 | 2 | ||||||
MIRT712075 | WDR37 | WD repeat domain 37 | ![]() |
![]() |
2 | 2 | ||||||
MIRT713643 | NCS1 | neuronal calcium sensor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT717999 | ZNF79 | zinc finger protein 79 | ![]() |
![]() |
2 | 2 | ||||||
MIRT718932 | TRIM66 | tripartite motif containing 66 | ![]() |
![]() |
2 | 2 | ||||||
MIRT719694 | STX6 | syntaxin 6 | ![]() |
![]() |
2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|